Jeffrey Peterson, associate professor of cancer biology with the Breast Cancer Translational Research Disease Group at Fox Chase Cancer Center, received a $1.4 million grant from the U.S. Department of Defense to evaluate and exploit the mechanisms of inducing programmed cell death using polyunsaturated fatty acids in triple-negative breast cancer.
An analysis by researchers from the International Agency for Research on Cancer casts doubt on validity of an endpoint used in key studies of multi-cancer detection tests.
